COMP <GO>
SLSN vs PG // ENTERPRISE SCALE & MARKET CAP
Solesence Inc. (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: SLSN 1
— PG 11
▲ ENTERPRISE SCALE & MARKET CAP LEADER: PG
LAST: $0.85 (+1.91%) • MKT CAP: $58.9M
market-cap
$58.9M
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
market-cap
$372.21B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SLSN VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SLSN | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.90% | 51.20% | -25.30 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.70% | 25.40% | -15.70 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 36.7x | 16.2x | +20.50 | PG | /valuation <GO> |
| Free Cash Flow Yield | -14.54% | 3.77% | -18.31 | PG | /fcf-yield <GO> |
| Operating Margin | 2.50% | 24.30% | -21.80 | PG | /operating-margins <GO> |
| Net Profit Margin | 2.90% | 19.00% | -16.10 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 18.60% | 0.30% | +18.30 | SLSN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.2 | 60.3 | -14.10 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 21.7x | +5.90 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $58.9M | $372.21B | -$372.15B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SLSN REV | PG REV | SLSN GROSS % | PG GROSS % | SLSN FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $62.1M | $84.28B | 25.9% | 51.2% | -$8.6M | $14.04B |
| FY 2024 | $52.3M | $84.04B | 30.9% | 51.4% | -$2.6M | $16.52B |
| FY 2023 | $37.3M | $82.01B | — | — | -$2.0M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SLSN // BETA —
PG // BETA 0.87